250 related articles for article (PubMed ID: 4175980)
1. [Anticoagulants].
Coelho E
Rev Hosp Clin Fac Med Sao Paulo; 1968 Jul; 23(4):217-28. PubMed ID: 4175980
[No Abstract] [Full Text] [Related]
2. [Treatment of thromboembolic conditions with thrombolytics and anticoagulants].
Wojczuk J
Wiad Lek; 1974 May; 27(10):877-82. PubMed ID: 4134634
[No Abstract] [Full Text] [Related]
3. The management of adequate anticoagulant therapy and its complications.
Royston GR
Vasc Dis; 1966 Oct; 3(5):295-304. PubMed ID: 4162445
[No Abstract] [Full Text] [Related]
4. [New therapeutic trends in myocardial infarct. Preliminary data on long-term treatment with fibrinolytic agents in angiopathic patients].
Molino N
Cardiol Prat; 1967 Oct; 18(5):51-7. PubMed ID: 4179097
[No Abstract] [Full Text] [Related]
5. [Anticoagulants. 43].
Striegler G
Pharm Prax; 1969 Dec; 12():279-87. PubMed ID: 4191772
[No Abstract] [Full Text] [Related]
6. [On the treatment of myocardial infarct with special reference to fibrinolytic substances].
Heinrich HG
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):38-45. PubMed ID: 4189370
[No Abstract] [Full Text] [Related]
7. [Recent developments in the field of fibrinolytics and anticoagulants].
Lechner K; Korninger C; Pabinger-Fasching I
Internist (Berl); 1984 Feb; 25(2):82-7. PubMed ID: 6368457
[No Abstract] [Full Text] [Related]
8. [Hypercoagulation and cancer. New treatment possibilities].
Lykke J; Nielsen HJ
Ugeskr Laeger; 2004 Aug; 166(33):2781-4. PubMed ID: 15344855
[No Abstract] [Full Text] [Related]
9. Disseminated intravascular coagulation. Heparin, anticoagulant and urokinase in experimental nephritic in mice.
Humair LM
Proc R Soc Med; 1968 Nov; 61(11 Part 1):1137-8. PubMed ID: 4177534
[No Abstract] [Full Text] [Related]
10. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
Zabolotskikh IB; Sin'kov SV; Klevko VA
Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
[No Abstract] [Full Text] [Related]
11. Rapidly progressive glomerulonephritis treated with anticoagulants.
Arieff AI; Pinggera WF
Arch Intern Med; 1972 Jan; 129(1):77-84. PubMed ID: 4550298
[No Abstract] [Full Text] [Related]
12. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
Gross R
Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
[No Abstract] [Full Text] [Related]
13. [Indications and clinical application of thrombosis prophylaxis. I].
Mittelkötter U; Reith HB; Thiede A
Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
[No Abstract] [Full Text] [Related]
14. [Anticoagulant drugs. Fibrinolytic drugs].
Cristea E
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1976; 20(2):105-7. PubMed ID: 133400
[No Abstract] [Full Text] [Related]
15. [Physiologic and physiopathologic bases of a rational anticoagulant therapy].
Raby C
Maroc Med; 1970 Mar; 50(533):129-45. PubMed ID: 5517522
[No Abstract] [Full Text] [Related]
16. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
Pelosio L; Marasco A; Puopolo G
Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
[No Abstract] [Full Text] [Related]
17. [Drug prophylaxis and therapy of thromboembolism].
Ohler WG
Gynakologe; 1988 Mar; 21(1):63-71. PubMed ID: 2453401
[No Abstract] [Full Text] [Related]
18. Drugs in the treatment of thrombo-embolic diseases--Part II.
Bouchier-Hayes D
Ir Med J; 1983 Mar; 76(3):155-9. PubMed ID: 6345455
[No Abstract] [Full Text] [Related]
19. Heparin therapy: current regimens and principles of monitoring.
Berry BR; Nantel S
Postgrad Med; 1996 Jun; 99(6):64-6, 69-76. PubMed ID: 8668639
[TBL] [Abstract][Full Text] [Related]
20. Protracted use of dicoumarol anticoagulants in the treatment of peripheral arteriopathies.
Raso AM; Roviera C; Scevola G
Panminerva Med; 1975; 16(7-8):238-45. PubMed ID: 45868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
